1
|
Begum F, Yousaf M, Iqbal S, Ullah N, Hussain A, Khan M, Khalid A, Algarni AS, Abdalla AN, Khan A, Lodhi MA, Al-Harrasi A. Inhibition of Acetylcholinesterase with Novel 1, 3, 4, Oxadiazole Derivatives: A Kinetic, In Silico, and In Vitro Approach. ACS OMEGA 2023; 8:46816-46829. [PMID: 38107974 PMCID: PMC10719919 DOI: 10.1021/acsomega.3c06298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/24/2023] [Accepted: 09/20/2023] [Indexed: 12/19/2023]
Abstract
Alzheimer's disease (AD) is a neurological disease that disturbs the memory, thinking skills, and behavior of the affected person. AD is a complex disease caused by the breakdown of acetylcholine via acetylcholinesterase (AChE). The present study aimed to assess the synthetic inhibitors of AChE that could be used to treat AD. For this purpose, synthetic compounds of oxadiazole derivatives (15-35) were evaluated and identified as promising inhibitors of AChE, exhibiting IC50 varying between 41.87 ± 0.67 and 1580.25 ± 0.7 μM. The kinetic parameters indicated that all the studied compounds bind to the allosteric site and decrease the efficiency of the AChE enzyme. In silico docking analysis showed that the majority of the compounds interact with the anionic subsite and Per-Arnt-Sim domain of AChE and are stabilized by various bonds including π-π and hydrogen bonding. The stability of the most potent compounds 16 and 17 with AChE interaction was confirmed by molecular dynamics simulations. Moreover, all compounds exhibited concentration-dependent calcium (Ca2+) antagonistic and spasmolytic activities. Among the whole series of oxadiazole derivatives, compounds 16 and 17 displayed the highest activities on spontaneous and potassium (K+)-induced contraction. Therefore, the AChE inhibitory potential, cytotoxicity safe profile, and Ca2+ antagonistic ability of these compounds make them potential therapeutic agents against AD and its associated problems in the future.
Collapse
Affiliation(s)
- Farida Begum
- Department
of Biochemistry, Abdul Wali Khan University
Mardan, Khyber
Pakhtunkhwa 23200, Pakistan
| | - Muhammad Yousaf
- Department
of Chemistry, Government Post Graduate College
Mardan, Khyber
Pakhtunkhwa 23200, Pakistan
| | - Sajid Iqbal
- Atta-ur-Rahman
School of Applied Biosciences (ASAB), National
University of Sciences and Technology (NUST), Islamabad 44000, Pakistan
| | - Nazif Ullah
- Department
of Biotechnology, Abdul Wali Khan University
Mardan, Khyber Pakhtunkhwa 23200, Pakistan
| | - Anwar Hussain
- Department
of Botany, Garden Campus, Abdul Wali Khan
University Mardan, Khyber Pakhtunkhwa 23200, Pakistan
| | - Momin Khan
- Department
of Chemistry, Abdul Wali Khan University
Mardan, Khyber Pakhtunkhwa 23200, Pakistan
| | - Asaad Khalid
- Substance
Abuse and Toxicology Research Center, Jazan
University, P.O. Box: 114, Jazan 45142, Saudi Arabia
| | - Alanood S. Algarni
- Department
of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia
| | - Ashraf N. Abdalla
- Department
of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia
| | - Ajmal Khan
- Natural
and Medical Sciences Research Centre, University
of Nizwa, Birkat-ul-Mouz, Nizwa 616, Sultanate of Oman
| | - Muhammad Arif Lodhi
- Department
of Biochemistry, Abdul Wali Khan University
Mardan, Khyber
Pakhtunkhwa 23200, Pakistan
| | - Ahmed Al-Harrasi
- Natural
and Medical Sciences Research Centre, University
of Nizwa, Birkat-ul-Mouz, Nizwa 616, Sultanate of Oman
| |
Collapse
|
2
|
Sharma P, Tripathi MK, Shrivastava SK. Cholinesterase as a Target for Drug Development in Alzheimer's Disease. Methods Mol Biol 2020; 2089:257-286. [PMID: 31773661 DOI: 10.1007/978-1-0716-0163-1_18] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Alzheimer's disease (AD) is an enormous healthcare challenge, and 50 million people are currently suffering from it. There are several pathophysiological mechanisms involved, but cholinesterase inhibitors remained the major target from the last 2-3 decades. Among four available therapeutics (donepezil, rivastigmine, galantamine, and memantine), three of them are cholinesterase inhibitors. Herein, we describe the role of acetylcholine sterase (AChE) and related hypothesis in AD along with the pharmacological and chemical aspects of the available cholinesterase inhibitors. This chapter discusses the development of several congeners and hybrids of available cholinesterase inhibitors along with their binding patterns in enzyme active sites.
Collapse
Affiliation(s)
- Piyoosh Sharma
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, India
| | - Manish Kumar Tripathi
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, India
| | - Sushant Kumar Shrivastava
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, India.
| |
Collapse
|
3
|
Mishra P, Sharma P, Tripathi PN, Gupta SK, Srivastava P, Seth A, Tripathi A, Krishnamurthy S, Shrivastava SK. Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions. Bioorg Chem 2019; 89:103025. [DOI: 10.1016/j.bioorg.2019.103025] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2019] [Revised: 04/13/2019] [Accepted: 05/30/2019] [Indexed: 12/20/2022]
|
4
|
Srivastava P, Tripathi PN, Sharma P, Shrivastava SK. Design, synthesis, and evaluation of novel N-(4-phenoxybenzyl)aniline derivatives targeting acetylcholinesterase, β-amyloid aggregation and oxidative stress to treat Alzheimer's disease. Bioorg Med Chem 2019; 27:3650-3662. [PMID: 31288978 DOI: 10.1016/j.bmc.2019.07.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2019] [Revised: 06/29/2019] [Accepted: 07/02/2019] [Indexed: 01/16/2023]
Abstract
Novel hybrids N-(4-phenoxybenzyl)aniline were designed, synthesized, and evaluated for their potential AChE inhibitory activity along with antioxidant potential. The inhibitory potential (IC50) of synthesized analogs was evaluated against human cholinesterases (hAChE and hBChE) using Ellman's method. Among all the tested compounds, 42 with trimethoxybenzene substituent showed maximum hAChE inhibition with the competitive type of enzyme inhibition (IC50 = 1.32 µM; Ki = 0.879 µM). Further, parallel artificial membrane permeation assay (PAMPA-BBB) showed favorable BBB permeability by most of the synthesized compounds. Meanwhile, compound 42 also inhibited AChE-induced Aβ aggregation (39.5-66.9%) in thioflavin T assay. The in vivo behavioral studies showed dose-dependent improvement in learning and memory by compound 42. The ex vivo studies also affirmed the significant AChE inhibition and antioxidant potential of compound 42 in brain homogenates.
Collapse
Affiliation(s)
- Pavan Srivastava
- Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221 005 India
| | - Prabhash Nath Tripathi
- Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221 005 India
| | - Piyoosh Sharma
- Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221 005 India
| | - Sushant Kumar Shrivastava
- Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221 005 India.
| |
Collapse
|
5
|
Shrivastava SK, Sinha SK, Srivastava P, Tripathi PN, Sharma P, Tripathi MK, Tripathi A, Choubey PK, Waiker DK, Aggarwal LM, Dixit M, Kheruka SC, Gambhir S, Shankar S, Srivastava RK. Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease. Bioorg Chem 2018; 82:211-223. [PMID: 30326403 DOI: 10.1016/j.bioorg.2018.10.009] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2018] [Revised: 10/02/2018] [Accepted: 10/04/2018] [Indexed: 12/11/2022]
Abstract
Based on the quantitative structure-activity relationship (QSAR), some novel p-aminobenzoic acid derivatives as promising cholinesterase enzyme inhibitors were designed, synthesized, characterized and evaluated to enhance learning and memory. The in vitro enzyme kinetic study of the synthesized compounds revealed the type of inhibition on the respective acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes. The in vivo studies of the synthesized compounds exhibited significant reversal of cognitive deficits in the animal models of amnesia as compared to standard drug donepezil. Further, the ex vivo studies in the specific brain regions like the hippocampus, hypothalamus, and prefrontal cortex regions also exhibited AChE inhibition comparable to standard donepezil. The in silico molecular docking and dynamics simulations studies of the most potent compound 22 revealed the consensual interactions at the active site pocket of the AChE.
Collapse
Affiliation(s)
- Sushant K Shrivastava
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, U.P., India.
| | - Saurabh K Sinha
- Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur 313001, Rajasthan, India
| | - Pavan Srivastava
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, U.P., India
| | - Prabhash N Tripathi
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, U.P., India
| | - Piyoosh Sharma
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, U.P., India
| | - Manish K Tripathi
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, U.P., India
| | - Avanish Tripathi
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, U.P., India
| | - Priyanka K Choubey
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, U.P., India
| | - Digambar K Waiker
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi 221005, U.P., India
| | - Lalit M Aggarwal
- Department of Radiotherapy & Radiation Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP 221 005, India
| | - Manish Dixit
- Department of Nuclear Medicine, SGPGIMS, Raebareli Road, Lucknow 226014, UP, India
| | - Subhash C Kheruka
- Department of Nuclear Medicine, SGPGIMS, Raebareli Road, Lucknow 226014, UP, India
| | - Sanjay Gambhir
- Department of Nuclear Medicine, SGPGIMS, Raebareli Road, Lucknow 226014, UP, India
| | - Sharmila Shankar
- Department of Genetics, Louisiana State University Health Sciences Center, 1700 Tulane Avenue, New Orleans, LA 70112, USA
| | - Rakesh K Srivastava
- Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, 1700 Tulane Avenue, New Orleans, LA 70112, USA
| |
Collapse
|
6
|
Wang X, Wang X, Guo Z. Metal-involved theranostics: An emerging strategy for fighting Alzheimer’s disease. Coord Chem Rev 2018. [DOI: 10.1016/j.ccr.2018.03.010] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
7
|
Duret G, Le Fouler V, Bisseret P, Bizet V, Blanchard N. Diels-Alder and Formal Diels-Alder Cycloaddition Reactions of Ynamines and Ynamides. European J Org Chem 2017. [DOI: 10.1002/ejoc.201700986] [Citation(s) in RCA: 55] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- Guillaume Duret
- CNRS, LCM UMR 7509; Université de Strasbourg; 67000 Strasbourg France
| | - Vincent Le Fouler
- CNRS, LCM UMR 7509; Université de Strasbourg; 67000 Strasbourg France
| | - Philippe Bisseret
- CNRS, LCM UMR 7509; Université de Strasbourg; 67000 Strasbourg France
| | - Vincent Bizet
- CNRS, LCM UMR 7509; Université de Strasbourg; 67000 Strasbourg France
| | - Nicolas Blanchard
- CNRS, LCM UMR 7509; Université de Strasbourg; 67000 Strasbourg France
| |
Collapse
|
8
|
Shrivastava SK, Srivastava P, Upendra T, Tripathi PN, Sinha SK. Design, synthesis and evaluation of some N -methylenebenzenamine derivatives as selective acetylcholinesterase (AChE) inhibitor and antioxidant to enhance learning and memory. Bioorg Med Chem 2017; 25:1471-1480. [DOI: 10.1016/j.bmc.2017.01.010] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2016] [Revised: 01/09/2017] [Accepted: 01/10/2017] [Indexed: 10/20/2022]
|
9
|
Duret G, Quinlan R, Yin B, Martin RE, Bisseret P, Neuburger M, Gandon V, Blanchard N. Intramolecular Inverse Electron-Demand [4 + 2] Cycloadditions of Ynamides with Pyrimidines: Scope and Density Functional Theory Insights. J Org Chem 2017; 82:1726-1742. [PMID: 28059511 DOI: 10.1021/acs.joc.6b02986] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
4-Aminopyridines are valuable scaffolds for the chemical industry in general, from life sciences to catalysis. We report herein a collection of structurally diverse polycyclic fused and spiro-4-aminopyridines that are prepared in only three steps from commercially available pyrimidines. The key step of this short sequence is a [4 + 2]/retro-[4 + 2] cycloaddition between a pyrimidine and an ynamide, which constitutes the first examples of ynamides behaving as electron-rich dienophiles in [4 + 2] cycloaddition reactions. In addition, running the ihDA/rDA reaction in continuous mode in superheated toluene, to overcome the limited scalability of MW reactions, results in a notable production increase compared to batch mode. Finally, density functional theory investigations shed light on the energetic and geometric requirements of the different steps of the ihDA/rDA sequence.
Collapse
Affiliation(s)
- Guillaume Duret
- Laboratoire de Chimie Moléculaire UMR 7509, Université de Strasbourg, CNRS , Strasbourg F-67000, France
| | - Robert Quinlan
- Laboratoire de Chimie Moléculaire UMR 7509, Université de Strasbourg, CNRS , Strasbourg F-67000, France
| | - Boyang Yin
- Laboratoire de Chimie Moléculaire UMR 7509, Université de Strasbourg, CNRS , Strasbourg F-67000, France
| | - Rainer E Martin
- Medicinal Chemistry, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche, Ltd. , Grenzacherstrasse 124, Basel CH-4070, Switzerland
| | - Philippe Bisseret
- Laboratoire de Chimie Moléculaire UMR 7509, Université de Strasbourg, CNRS , Strasbourg F-67000, France
| | - Markus Neuburger
- Department of Chemistry, University of Basel , Spitalstrasse 51, Basel CH-4056, Switzerland
| | - Vincent Gandon
- Institut de Chimie Moléculaire et des Matériaux d'Orsay, CNRS UMR 8182, Université Paris-Sud, Université Paris-Saclay , bâtiment 420, Orsay cedex 91405, France.,Institut de Chimie des Substances Naturelles, CNRS UPR 2301, Université Paris-Sud, Université Paris-Saclay , 1 av. de la Terrasse, Gif-sur-Yvette 91198, France
| | - Nicolas Blanchard
- Laboratoire de Chimie Moléculaire UMR 7509, Université de Strasbourg, CNRS , Strasbourg F-67000, France
| |
Collapse
|
10
|
Silva DES, Cali MP, Pazin WM, Carlos-Lima E, Salles Trevisan MT, Venâncio T, Arcisio-Miranda M, Ito AS, Carlos RM. Luminescent Ru(II) Phenanthroline Complexes as a Probe for Real-Time Imaging of Aβ Self-Aggregation and Therapeutic Applications in Alzheimer’s Disease. J Med Chem 2016; 59:9215-9227. [DOI: 10.1021/acs.jmedchem.6b01130] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Affiliation(s)
- Debora E. S. Silva
- Departamento
de Química, Universidade Federal de São Carlos, São
Carlos, São Paulo 13565-905, Brazil
| | - Mariana P. Cali
- Departamento
de Química, Universidade Federal de São Carlos, São
Carlos, São Paulo 13565-905, Brazil
| | - Wallance M. Pazin
- Departamento de
Física, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, USP, Ribeirão Preto, São Paulo 14040-901, Brazil
| | - Estevão Carlos-Lima
- Departamento
de Biofísica, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, São Paulo 04023-062, Brazil
| | - Maria Teresa Salles Trevisan
- Departamento
de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Ceará Fortaleza, 60451-970, Brazil
| | - Tiago Venâncio
- Departamento
de Química, Universidade Federal de São Carlos, São
Carlos, São Paulo 13565-905, Brazil
| | - Manoel Arcisio-Miranda
- Departamento
de Biofísica, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, São Paulo 04023-062, Brazil
| | - Amando S. Ito
- Departamento de
Física, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, USP, Ribeirão Preto, São Paulo 14040-901, Brazil
| | - Rose M. Carlos
- Departamento
de Química, Universidade Federal de São Carlos, São
Carlos, São Paulo 13565-905, Brazil
| |
Collapse
|
11
|
Sinha SK, Shrivastava SK. Synthesis, evaluation and molecular dynamics study of some new 4-aminopyridine semicarbazones as an antiamnesic and cognition enhancing agents. Bioorg Med Chem 2013; 21:5451-60. [PMID: 23810675 DOI: 10.1016/j.bmc.2013.06.003] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2013] [Revised: 06/02/2013] [Accepted: 06/04/2013] [Indexed: 11/30/2022]
Abstract
Some new semicarbazones of 4-aminopyridine were synthesized and evaluated for antiamnesic, cognition enhancing and anticholinesterase activities. The results illustrated a significant cognition enhancing effect on elevated plus maze model with a significant reversal of scopolamine-induced amnesia. A significant inhibition in acetycholinesterase (AChE) activity by all the synthesized compounds in specific brain regions that is, prefrontal cortex, hippocampus and hypothalamus was observed. Compound 4APi exhibited significant antiamnesic and cognition enhancing activity which was comparable with standard drug donepezil. Its enzyme kinetic study revealed a non-competitive inhibition of AChE and a competitive inhibition of butyrylcholinesterase (BChE). Docking studies predicted the binding modes of these compounds in AChE active site, which were further processed for molecular dynamics simulation for calculating binding free energies using Molecular Mechanics-Generalized Born Surface Area (MM/GBSA). All the computational study confirmed their consensual interaction with AChE justifying the experimental outcome.
Collapse
Affiliation(s)
- Saurabh K Sinha
- Pharmaceutical Chemistry Research Laboratory, Department of Pharmaceutics, Indian Institute of Technology, Banaras Hindu University, Varanasi, U.P. 221005, India
| | | |
Collapse
|